{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:15:38Z","timestamp":1792098938674,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1002\/jps.21158","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T21:52:48Z","timestamp":1187992368000},"page":"1530-1542","source":"Crossref","is-referenced-by-count":223,"title":["PLGA Nanoparticles for Oral Delivery of Hydrophobic Drugs: Influence of Organic Solvent on Nanoparticle Formation and Release Behavior In Vitro and In Vivo Using Estradiol as a Model Drug"],"prefix":"10.1016","volume":"97","author":[{"given":"D.K.","family":"Sahana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.V.Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21158_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(95)04118-4","article-title":"Oral bioavailability of beta estradiol and prodrugs tested in rats, pigs and dogs","volume":"127","author":"Lokind","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21158_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1166\/jbn.2005.033","article-title":"Pharmaceutical aspects of polymeric nanoparticles for oral delivery","volume":"1","author":"Bhardwaj","year":"2005","journal-title":"J Biomed Nanotechnol"},{"key":"10.1002\/jps.21158_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","article-title":"Nanoparticle uptake by the oral route: Fulfilling its potential?","volume":"2","author":"Florence","year":"2005","journal-title":"Drug Discov Today Technol"},{"key":"10.1002\/jps.21158_bb0025","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/A:1016085108889","article-title":"Gastrointestinal uptake of biodegradable microparticles: Effect of particle size","volume":"13","author":"Desai","year":"1996","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012029517394","article-title":"The oral absorption of micro\u2010 and nanoparticulates: Neither exceptional nor unusual","volume":"14","author":"Florence","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(98)00037-4","article-title":"The effect of physical barriers and properties on the oral absorption of particulates","volume":"34","author":"Norris","year":"1998","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21158_bb0040","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide\u2010co\u2010glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21158_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i5.20","article-title":"PLGA nanoparticles in drug delivery: The state of the art","volume":"21","author":"Bala","year":"2004","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.21158_bb0050","series-title":"The Merck Index. An encyclopedia of chemicals, drugs and biologicals","first-page":"13","author":"Budavari","year":"2001"},{"key":"10.1002\/jps.21158_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(97)01647-7","article-title":"Microencapsulation techniques using ethyl acetate as a dispersed solvent: Effects of its extraction rate on the characteristics of PLGA microspheres","volume":"47","author":"Sah","year":"1997","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0168-3659(99)00219-9","article-title":"Controlled release of \u03b2\u2010estradiol from PLAGA microparticles: The effect of organic phase solvent on encapsulation and release","volume":"65","author":"Birnbaum","year":"2000","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11095-005-8418-y","article-title":"Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy","volume":"23","author":"Hariharan","year":"2006","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size\u2010dependent bioadhesion of micro\u2010 and nanoparticulate carriers to the inflammed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2005.04.006","article-title":"Poly(lactide\u2010co\u2010glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice","volume":"61","author":"Shakweh","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21158_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt030432","article-title":"The effect of cosolvents on the formulation of nanoparticles from low\u2010molecular\u2010weight poly(l)lactide","volume":"3","author":"Peltonen","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/jps.21158_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.colsurfa.2005.10.064","article-title":"The effect of type of organic phase solvents on the particle size of poly(D,L\u2010lactide\u2010co\u2010glycolide) nanoparticles","volume":"276","author":"Song","year":"2006","journal-title":"Coll Surf A Physicochem Eng Aspects"},{"key":"10.1002\/jps.21158_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s003960050006","article-title":"Rheological behavior in the didodecyldimethylammonium bromide\/water system","volume":"278","author":"Soltero","year":"2000","journal-title":"Colloid Polym Sci"},{"key":"10.1002\/jps.21158_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0927-7757(00)00825-6","article-title":"Preparation of PLGA nanoparticles containing estrogen by emulsification\u2010diffusion method","volume":"182","author":"Kwon","year":"2001","journal-title":"Coll Surf A Physicochem Eng Aspects"},{"key":"10.1002\/jps.21158_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(02)00058-3","article-title":"Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study","volume":"238","author":"Vandervoort","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21158_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-5173(88)90073-7","article-title":"Solvent selection in the preparation of poly(DL\u2010lactide) microspheres prepared by the solvent evaporation method","volume":"43","author":"Bodmeier","year":"1988","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21158_bb0110","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.20094","article-title":"Solid\u2010state solubility influences encapsulation and release of hydrophobic drugs from PLGA\/PLA nanoparticles","volume":"93","author":"Panyam","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21158_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-3659(03)00194-9","article-title":"Biodegradable microspheres for protein delivery","volume":"90","author":"Sinha","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0142-9612(96)85755-3","article-title":"Mechanisms of polymer degradation and erosion","volume":"17","author":"Gopferich","year":"1996","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21158_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-3659(03)00328-6","article-title":"Polymer degradation and in vitro release of a model protein from poly(D,L\u2010lactide\u2010co\u2010glycolide) nano\u2010 and microparticles","volume":"92","author":"Panyam","year":"2003","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0927-7765(99)00105-8","article-title":"Sustained release of 17\u03b2\u2010estradiol from poly(lactide\u2010co\u2010glycolide) microspheres in vitro and in vivo","volume":"17","author":"Mogi","year":"2000","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.21158_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0927-7765(00)00148-X","article-title":"Pulsatile drug release from poly(lactide\u2010co\u2010glycolide) microspheres: How does composition of the polymer matrix affect the time interval between the initial burst and the pulsatile release of drugs?","volume":"19","author":"Makino","year":"2000","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.21158_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21158_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly(lactide\u2010co\u2010glycolide) nanoparticles affects their physical properties and cellular uptake","volume":"82","author":"Sahoo","year":"2002","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-5173(92)90202-D","article-title":"Nanosphere and microsphere uptake via Peyer's patches: Observation of the rate of uptake in rat after a single oral dose","volume":"86","author":"Jani","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21158_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","article-title":"Binding and uptake of biodegradable poly\u2010lactide micro\u2010 and nanoparticles in intestinal epithelia","volume":"6","author":"McClean","year":"1998","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.21158_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(02)00461-1","article-title":"Positively charged nanoparticles for improving the oral bioavailability of cyclosporine\u2010A","volume":"249","author":"El\u2010Shabouri","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21158_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.01.016","article-title":"Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo","volume":"119","author":"Mittal","year":"2007","journal-title":"J Control Release"},{"key":"10.1002\/jps.21158_bb0170","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1023\/A:1012126301290","article-title":"The mechanism of uptake of biodegradable microparticles in Caco\u20102 cells is size dependent","volume":"14","author":"Desai","year":"1997","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanosphere","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1002\/jps.21158_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1023\/A:1018965121222","article-title":"Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes","volume":"11","author":"Harashima","year":"1994","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21158_bb0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the preparation process for human serum albumin (HSA) nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916325497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916325497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T18:59:12Z","timestamp":1546628352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916325497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0022354916325497"],"URL":"https:\/\/doi.org\/10.1002\/jps.21158","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}